RIBOMIC Inc.TSE 4591

株式会社リボミック · Pharmaceutical · FY ends Mar

Share price at FY-end
—
FY ending Mar 2026
Market cap at FY-end
—
Dividend per share
—
Avg. director pay
¥27.0M
Internal directors

Top 10 shareholders

#ShareholderSharesStakeValueDividends
1 BNP Paribas London Branch For Prime Brokerage Clearance Acc For Third Party 1,533,000 2.82% — —
2 BNY GCM CLIENT ACCOUNT JPRD AC ISG 992,147 1.82% — —
3 松井証券株式会社 855,400 1.57% — —
4 UBS AG LONDON A/C IPB SEGREGATED CLIENT ACCOUNT 632,600 1.16% — —
5 大和証券株式会社 598,100 1.10% — —
6 全薬工業株式会社 575,800 1.06% — —
7 中村 義一 568,000 1.04% — —
8 楽天証券株式会社共有口 542,800 0.99% — —
9 湯浅 英之 500,000 0.92% — —
10 株式会社SBI証券 395,840 0.72% — —

Officers' holdings and pay

NameTitleSharesValuePay
中村 義一 President & Representative Director 568,000 — —
大岩 久人 Director — — —
安達 健朗 Director 3,300 — —
西畑 利明 Director — — —
松藤 千弥 Director 40,000 — —
藤原 俊伸 Director — — —
五十嵐 章之 Audit & Supervisory Board Member — — —
矢部 豊 Audit & Supervisory Board Member — — —
藤井 康弘 Audit & Supervisory Board Member — — —

Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.

Per-share data by fiscal year

Fiscal yearPriceEPSP/EDividendShares issued
FY ending Mar 2026 — ¥-23.07 — — 54,332,640
FY ending Mar 2025 — ¥-25.21 — — 44,613,940
FY ending Mar 2024 — ¥-28.70 — — 36,022,040
Source: annual securities reports on EDINET. Values are estimates. Methodology